Molecular structure of starch in
daily diet is closely associated
with diabetes management. By enzymatically reassembling α-1,4
and α-1,6 glycosidic bonds in starch molecules, we have synthesized
an innovative short-clustered maltodextrin (SCMD) which slowly releases
glucose during digestion. Here, we investigated the potential benefits
of the SCMD-containing diet using diabetic db/db mice. As compared to a diet with normal starch, this
dietary style greatly attenuated hyperglycemia and repaired symptoms
associated with diabetes. Additionally, in comparison with acarbose
(an α-glucosidase inhibitor) administration, the SCMD-containing
diet more effectively accelerated brown adipose activation and improved
energy metabolism of db/db mice.
Furthermore, the SCMD-containing diet was a more suitable approach
to improving the intestinal microflora than acarbose administration,
especially the proliferation of Mucispirillum, Akkermansia, and Bifidobacterium. These results reveal a novel strategy
for diabetes management based on enzymatically rebuilding starch molecules
in the daily diet.